- Home
- DAO vs PLRX Comparison
DAO vs PLRX Comparison
Compare DAO & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAO
- PLRX
- Stock Information
- Founded
- DAO 2006
- PLRX 2015
- Country
- DAO China
- PLRX United States
- Employees
- DAO N/A
- PLRX N/A
- Industry
- DAO Other Consumer Services
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- DAO Real Estate
- PLRX Health Care
- Exchange
- DAO Nasdaq
- PLRX Nasdaq
- Market Cap
- DAO 578.5M
- PLRX 641.5M
- IPO Year
- DAO 2019
- PLRX 2020
- Fundamental
- Price
- DAO $7.65
- PLRX $14.37
- Analyst Decision
- DAO
- PLRX Strong Buy
- Analyst Count
- DAO 0
- PLRX 7
- Target Price
- DAO N/A
- PLRX $40.50
- AVG Volume (30 Days)
- DAO 169.4K
- PLRX 459.1K
- Earning Date
- DAO 11-14-2024
- PLRX 11-07-2024
- Dividend Yield
- DAO N/A
- PLRX N/A
- EPS Growth
- DAO N/A
- PLRX N/A
- EPS
- DAO 0.07
- PLRX N/A
- Revenue
- DAO $822,103,071.00
- PLRX N/A
- Revenue This Year
- DAO $11.98
- PLRX N/A
- Revenue Next Year
- DAO $14.00
- PLRX N/A
- P/E Ratio
- DAO $117.41
- PLRX N/A
- Revenue Growth
- DAO 7.53
- PLRX N/A
- 52 Week Low
- DAO $2.86
- PLRX $10.22
- 52 Week High
- DAO $8.01
- PLRX $19.62
- Technical
- Relative Strength Index (RSI)
- DAO 71.94
- PLRX 53.62
- Support Level
- DAO $7.18
- PLRX $13.14
- Resistance Level
- DAO $8.01
- PLRX $15.27
- Average True Range (ATR)
- DAO 0.53
- PLRX 0.77
- MACD
- DAO 0.09
- PLRX -0.04
- Stochastic Oscillator
- DAO 82.61
- PLRX 46.24
About DAO Youdao Inc. each representing one
Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and Youdao Pocket Translator.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.